» Articles » PMID: 39856771

An Animal Model of Severe Acute Respiratory Distress Syndrome for Translational Research

Overview
Journal Lab Anim Res
Date 2025 Jan 25
PMID 39856771
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Despite the fact that an increasing number of studies have focused on developing therapies for acute lung injury, managing acute respiratory distress syndrome (ARDS) remains a challenge in intensive care medicine. Whether the pathology of animal models with acute lung injury in prior studies differed from clinical symptoms of ARDS, resulting in questionable management for human ARDS. To evaluate precisely the therapeutic effect of transplanted stem cells or medications on acute lung injury, we developed an animal model of severe ARDS with lower lung function, capable of keeping the experimental animals survive with consistent reproducibility. Establishing this animal model could help develop the treatment of ARDS with higher efficiency.

Results: In this approach, we intratracheally delivered bleomycin (BLM, 5 mg/rat) into rats' left trachea via a needle connected with polyethylene tube, and simultaneously rotated the rats to the left side by 60 degrees. Within seven days after the injury, we found that arterial blood oxygen saturation (SpO) significantly decreased to 83.7%, partial pressure of arterial oxygen (PaO) markedly reduced to 65.3 mmHg, partial pressure of arterial carbon dioxide (PaCO) amplified to 49.2 mmHg, and the respiratory rate increased over time. Morphologically, the surface of the left lung appeared uneven on Day 1, the alveoli of the left lung disappeared on Day 2, and the left lung shrank on Day 7. A histological examination revealed that considerable cell infiltration began on Day 1 and lasted until Day 7, with a larger area of cell infiltration. Serum levels of IL-5, IL-6, IFN-γ, MCP-1, MIP-2, G-CSF, and TNF-α substantially rose on Day 7.

Conclusions: This modified approach for BLM-induced lung injury provided a severe, stable, and one-sided (left-lobe) ARDS animal model with consistent reproducibility. The physiological symptoms observed in this severe ARDS animal model are entirely consistent with the characteristics of clinical ARDS. The establishment of this ARDS animal model could help develop treatment for ARDS.

References
1.
Zhang E, Yang Y, Zhang J, Ding G, Chen S, Peng C . Efficacy of bone marrow mesenchymal stem cell transplantation in animal models of pulmonary fibrosis after exposure to bleomycin: A meta-analysis. Exp Ther Med. 2019; 17(3):2247-2255. PMC: 6395999. DOI: 10.3892/etm.2019.7205. View

2.
Mokra D, Kosutova P . Biomarkers in acute lung injury. Respir Physiol Neurobiol. 2014; 209:52-8. DOI: 10.1016/j.resp.2014.10.006. View

3.
Bellani G, Laffey J, Pham T, Fan E, Brochard L, Esteban A . Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. JAMA. 2016; 315(8):788-800. DOI: 10.1001/jama.2016.0291. View

4.
Chu K, Yeh C, Kuo F, Lin W, Hsu C, Chen T . Comparison of reversal of rat pulmonary fibrosis of nintedanib, pirfenidone, and human umbilical mesenchymal stem cells from Wharton's jelly. Stem Cell Res Ther. 2020; 11(1):513. PMC: 7702727. DOI: 10.1186/s13287-020-02012-y. View

5.
Joelsson J, Ingthorsson S, Kricker J, Gudjonsson T, Karason S . Ventilator-induced lung-injury in mouse models: Is there a trap?. Lab Anim Res. 2021; 37(1):30. PMC: 8554750. DOI: 10.1186/s42826-021-00108-x. View